Jieqiong Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jieqiong Zhang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ciai Yan
Department of First Clinical School, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, PR China
1 shared publication - Guanxun Zhang
Department of First Clinical School, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, PR China
1 shared publication - Wei-Ping Cheng
Department of Research Centre of Translational Medicine of Traditional Chinese Medicine, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, PR China
1 shared publication - Weiping Cheng
Acupuncture Department II, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, PR China
1 shared publication - Zhixin Sun
Department of Preventive Treatment Centre, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, PR China
1 shared publication
Latest Publications
- Open Access
- 22 May 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (21) , e48784
Association between serum cotinine levels and cognitive function in Americans aged 60 and older: A cross-sectional study
Cognitive decline poses a major public health burden on the aging population, necessitating the identification of modifiable risk factors. Cotinine, a key nicotine metabolite and an established biomarker of tobacco exposure, has demonstrated biologically plausible associations with cognitive function. This study examined the association between serum cotinine levels and cognitive function in US adults aged ≥60 years. We conducted a cross-sectional study including 2781 participants aged ≥60 years, using data from the United States National Health and Nutrition Examination Survey from 2011 to 2014. Sampling weights were applied in all analyses to account for the complex survey design and ensure national representativeness. We used multivariable linear regression supplemented by stratified analyses, sensitivity analyses, and restricted cubic splines to model nonlinear associations. Multivariable-adjusted analyses showed a significant inverse association between serum cotinine levels and cognitive function (β = −0.85, 95% confidence interval: −1.62 to −0.08, P = .034). Subgroup analyses consistently demonstrated this inverse association across strata (all P for interaction > .05). Sensitivity analyses supported the robustness of these findings. Curve fitting revealed an L-shaped relationship (inflection point: log 2 cotinine = −0.16; 95% confidence interval: −0.30 to −0.03, P for nonlinearity = .022), with a significant inverse association observed below this threshold ( P = .017), whereas the association plateaued above the threshold ( P = .063), suggesting a potential threshold-dependent association between serum cotinine and cognitive function. This cross-sectional study found a significant inverse association between serum cotinine levels and cognitive function in older adults in the United States, which was observed as an L-shaped relationship with a threshold of log 2 cotinine = −0.16. These findings contribute to evidence on tobacco exposure and cognitive outcomes in aging populations.
- 22 May 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (21) , e48784
Open AccessAssociation between serum cotinine levels and cognitive function in Americans aged 60 and older: A cross-sectional study
Cognitive decline poses a major public health burden on the aging population, necessitating the identification of modifiable risk factors. Cotinine, a key nicotine metabolite and an established biomarker of tobacco exposure, has demonstrated biologically plausible associations with cognitive function. This study examined the association between serum cotinine levels and cognitive function in US adults aged ≥60 years. We conducted a cross-sectional study including 2781 participants aged ≥60 years, using data from the United States National Health and Nutrition Examination Survey from 2011 to 2014. Sampling weights were applied in all analyses to account for the complex survey design and ensure national representativeness. We used multivariable linear regression supplemented by stratified analyses, sensitivity analyses, and restricted cubic splines to model nonlinear associations. Multivariable-adjusted analyses showed a significant inverse association between serum cotinine levels and cognitive function (β = −0.85, 95% confidence interval: −1.62 to −0.08, P = .034). Subgroup analyses consistently demonstrated this inverse association across strata (all P for interaction > .05). Sensitivity analyses supported the robustness of these findings. Curve fitting revealed an L-shaped relationship (inflection point: log 2 cotinine = −0.16; 95% confidence interval: −0.30 to −0.03, P for nonlinearity = .022), with a significant inverse association observed below this threshold ( P = .017), whereas the association plateaued above the threshold ( P = .063), suggesting a potential threshold-dependent association between serum cotinine and cognitive function. This cross-sectional study found a significant inverse association between serum cotinine levels and cognitive function in older adults in the United States, which was observed as an L-shaped relationship with a threshold of log 2 cotinine = −0.16. These findings contribute to evidence on tobacco exposure and cognitive outcomes in aging populations.